Suppr超能文献

侵袭性脑膜炎球菌病的危险因素:对法国国家公共卫生保险数据库的回顾性分析。

Risk factors for invasive meningococcal disease: a retrospective analysis of the French national public health insurance database.

作者信息

Taha Muhamed-Kheir, Weil-Olivier Catherine, Bouée Stéphane, Emery Corinne, Nachbaur Gaëlle, Pribil Céline, Loncle-Provot Véronique

机构信息

Invasive Bacterial Infections Unit, Institut Pasteur, Paris, France.

Service de Pédiatrie, Université de Paris VII Diderot, Paris, France.

出版信息

Hum Vaccin Immunother. 2021 Jun 3;17(6):1858-1866. doi: 10.1080/21645515.2020.1849518. Epub 2021 Jan 15.

Abstract

Vaccination of at-risk populations against is an important strategy to prevent invasive meningococcal disease (IMD). The objective of this study was to characterize preexisting risk factors in patients with IMD and to compare their relative importance. This case-control analysis was performed in the French national public health insurance database (). Cases consisted of all people hospitalized for IMD in France over a six-year period (2012-2017). Controls were matched by age, gender, and district of residence. Medical risk factors were identified from ICD-10 codes in the . Socioeconomic risk factors studied were low household income and social deprivation of the municipality of residence. Associations of these risk factors with hospitalization for IMD were quantified as odds ratios (ORs) between cases and controls with their 95% confidence intervals (95%CI). The medical risk factors showing the most robust associations were congenital immunodeficiency (OR: 39.1 [95%CI: 5.1-299], acquired immunodeficiency (10.3 [4.5-24.0]) and asplenia/hyposplenia (6.7 [3.7-14.7]). In addition, certain chronic medical conditions, such as autoimmune disorders (5.4 [2.5-11.8]), hemophilia (4.7 [1.8-12.2]) and severe chronic respiratory disorders (4.3 [3.1-6.2]) were also strongly associated, as was low household income (1.68 [1.49-1.80]). In conclusion, this study has documented potential risk factors associated with hospitalization for IMD in a large and comprehensive sample of individuals with IMD in France. Several of the risk factors identified may help identify groups who could benefit from targeted prevention measures (such as vaccination) in order to reduce the burden of IMD.

摘要

对高危人群进行针对[疾病名称未给出]的疫苗接种是预防侵袭性脑膜炎球菌病(IMD)的一项重要策略。本研究的目的是描述IMD患者预先存在的风险因素,并比较它们的相对重要性。这项病例对照分析是在法国国家公共医疗保险数据库([数据库名称未给出])中进行的。病例包括在六年期间(2012 - 2017年)在法国因IMD住院的所有人。对照按年龄、性别和居住地区进行匹配。从[数据库名称未给出]中的国际疾病分类第十版(ICD - 10)编码中识别医疗风险因素。所研究的社会经济风险因素是家庭收入低和居住市镇的社会剥夺情况。这些风险因素与因IMD住院之间的关联以病例与对照之间的比值比(OR)及其95%置信区间(95%CI)进行量化。显示出最强烈关联的医疗风险因素是先天性免疫缺陷(OR:39.1 [95%CI:5.1 - 299])、获得性免疫缺陷(10.3 [4.5 - 24.0])和无脾/脾功能减退(6.7 [3.7 - 14.7])。此外,某些慢性疾病状况,如自身免疫性疾病(5.4 [2.5 - 11.8])、血友病(4.7 [1.8 - 12.2])和严重慢性呼吸系统疾病(4.3 [3.1 - 6.2])也有很强的关联,家庭收入低(1.68 [1.49 - 1.80])也是如此。总之,本研究在法国一个大型且全面的IMD患者样本中记录了与因IMD住院相关的潜在风险因素。所确定的一些风险因素可能有助于识别那些可能从针对性预防措施(如疫苗接种)中受益的群体,以减轻IMD的负担。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c79/8115611/dfabbe83644f/KHVI_A_1849518_F0001_C.jpg

相似文献

1
Risk factors for invasive meningococcal disease: a retrospective analysis of the French national public health insurance database.
Hum Vaccin Immunother. 2021 Jun 3;17(6):1858-1866. doi: 10.1080/21645515.2020.1849518. Epub 2021 Jan 15.
2
Care pathways in invasive meningococcal disease: a retrospective analysis of the French national public health insurance database.
Hum Vaccin Immunother. 2022 Dec 31;18(1):2021764. doi: 10.1080/21645515.2021.2021764. Epub 2022 Feb 22.
3
Characteristics and changes in invasive meningococcal disease epidemiology in France, 2006-2015.
J Infect. 2017 Jun;74(6):564-574. doi: 10.1016/j.jinf.2017.02.011. Epub 2017 Mar 7.
5
Comorbidity Increases the Risk of Invasive Meningococcal Disease in Adults.
Clin Infect Dis. 2022 Aug 24;75(1):125-130. doi: 10.1093/cid/ciab856.
6
Equity in vaccination policies to overcome social deprivation as a risk factor for invasive meningococcal disease.
Expert Rev Vaccines. 2022 May;21(5):659-674. doi: 10.1080/14760584.2022.2052048. Epub 2022 Mar 29.
8
Epidemiology of serogroup C and Y invasive meningococcal disease (IMD) in Ontario, 2000-2013: Vaccine program impact assessment.
Vaccine. 2015 Oct 13;33(42):5678-5683. doi: 10.1016/j.vaccine.2015.08.023. Epub 2015 Aug 20.
10
Need for Optimisation of Immunisation Strategies Targeting Invasive Meningococcal Disease in the Netherlands.
Int J Health Policy Manag. 2015 Sep 13;4(11):757-61. doi: 10.15171/ijhpm.2015.168.

引用本文的文献

1
Inactivation of the porB gene reduces the virulence of Neisseria meningitidis in transgenic mice.
BMC Microbiol. 2025 Aug 16;25(1):515. doi: 10.1186/s12866-025-04246-3.
2
Meningococcal B Vaccines as a Paradigm of Safe and Effective Vaccines for Children.
Vaccines (Basel). 2025 Jul 21;13(7):770. doi: 10.3390/vaccines13070770.
3
A Rare Case of Viral Meningitis and Probable Metabolic Encephalopathy in a Renal Transplant Patient.
Cureus. 2024 Dec 30;16(12):e76602. doi: 10.7759/cureus.76602. eCollection 2024 Dec.
4
4CMenB journey to the 10-year anniversary and beyond.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2357924. doi: 10.1080/21645515.2024.2357924. Epub 2024 Jul 8.
5
Invasive meningococcal disease in older adults: current perspectives and call for action.
Eur Geriatr Med. 2024 Jun;15(3):729-741. doi: 10.1007/s41999-024-00969-0. Epub 2024 May 6.
6
Risk of Invasive Meningococcal Disease in Preterm Infants.
Open Forum Infect Dis. 2024 Apr 15;11(4):ofae164. doi: 10.1093/ofid/ofae164. eCollection 2024 Apr.
7
Geographical distribution of invasive meningococcal disease and carriage: A spatial analysis.
Epidemiol Infect. 2024 Jan 18;152:e22. doi: 10.1017/S0950268824000116.
8
How can we improve the care of patients with schizophrenia in the real-world? A population-based cohort study of 456,003 patients.
Mol Psychiatry. 2023 Dec;28(12):5328-5336. doi: 10.1038/s41380-023-02154-4. Epub 2023 Jul 21.
9
Meningococcal B Immunisation in Adults and Potential Broader Immunisation Strategies: A Narrative Review.
Infect Dis Ther. 2023 Sep;12(9):2193-2219. doi: 10.1007/s40121-023-00836-8. Epub 2023 Jul 6.
10
Review of the unmet medical need for vaccination in adults with immunocompromising conditions: An Indian perspective.
Hum Vaccin Immunother. 2023 Aug 1;19(2):2224186. doi: 10.1080/21645515.2023.2224186.

本文引用的文献

1
Meningococcal infections among refugees and immigrants: silent threats of past, present and future.
Hum Vaccin Immunother. 2020 Nov 1;16(11):2781-2786. doi: 10.1080/21645515.2020.1744979. Epub 2020 Apr 29.
2
Recent changes of invasive meningococcal disease in France: arguments to revise the vaccination strategy in view of those of other countries.
Hum Vaccin Immunother. 2020 Oct 2;16(10):2518-2523. doi: 10.1080/21645515.2020.1729030. Epub 2020 Mar 25.
3
Success of 4CMenB in preventing meningococcal disease: evidence from real-world experience.
Arch Dis Child. 2020 Aug;105(8):784-790. doi: 10.1136/archdischild-2019-318047. Epub 2020 Feb 6.
4
Hospital burden of pulmonary arterial hypertension in France.
PLoS One. 2019 Sep 19;14(9):e0221211. doi: 10.1371/journal.pone.0221211. eCollection 2019.
5
Meningococcal pneumonia: a review.
Pneumonia (Nathan). 2019 Aug 25;11:3. doi: 10.1186/s41479-019-0062-0. eCollection 2019.
6
Prevalence of patients hospitalised for male breast cancer in France using the French nationwide hospital administrative database.
Eur J Cancer Care (Engl). 2019 Sep;28(5):e13117. doi: 10.1111/ecc.13117. Epub 2019 Jun 24.
7
Identifying chronic thromboembolic pulmonary hypertension through the French national hospital discharge database.
PLoS One. 2019 Apr 18;14(4):e0214649. doi: 10.1371/journal.pone.0214649. eCollection 2019.
8
Invasive Meningococcal Disease in the Vaccine Era.
Front Pediatr. 2018 Nov 9;6:321. doi: 10.3389/fped.2018.00321. eCollection 2018.
9
Systematic Review of Invasive Meningococcal Disease: Sequelae and Quality of Life Impact on Patients and Their Caregivers.
Infect Dis Ther. 2018 Dec;7(4):421-438. doi: 10.1007/s40121-018-0213-2. Epub 2018 Sep 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验